Robert Dwyer Nolan
Directeur/Bestuurslid bij Phico Therapeutics Ltd.
Actieve functies van Robert Dwyer Nolan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - | - |
Loopbaan van Robert Dwyer Nolan
Eerdere bekende functies van Robert Dwyer Nolan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GENEDRIVE PLC | Directeur/Bestuurslid | 01-01-2004 | 31-12-2018 |
Independent Dir/Board Member | 20-03-2015 | 31-12-2018 | |
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom. | Directeur/Bestuurslid | - | 01-10-2008 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-1989 | 01-01-2004 |
Cardiff Biologicals Ltd. | Voorzitter | - | - |
Oprichter | - | - | |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Directeur/Bestuurslid | 15-11-2010 | - |
Cardiff Protides Ltd. | Voorzitter | - | - |
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology NeuTec Pharma Ltd. develops biopharmaceutical products. It specializes in the development of genetically recombinant antibodies, or “grabs”, for the treatment of life-threatening infections. The firm's products include Mycograb and Aurograb. The company was founded in 1997 and is headquartered in Camberley, the United Kingdom. | Directeur/Bestuurslid | 01-10-2003 | - |
Opleiding van Robert Dwyer Nolan
King's College London | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 10 |
Operationeel
Director/Board Member | 5 |
Chairman | 2 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 6 |
Commercial Services | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
GENEDRIVE PLC | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom. | Health Technology |
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology NeuTec Pharma Ltd. develops biopharmaceutical products. It specializes in the development of genetically recombinant antibodies, or “grabs”, for the treatment of life-threatening infections. The firm's products include Mycograb and Aurograb. The company was founded in 1997 and is headquartered in Camberley, the United Kingdom. | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Cardiff Protides Ltd. | Commercial Services |
Cardiff Biologicals Ltd. | Commercial Services |
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Beurs
- Insiders
- Robert Dwyer Nolan
- Ervaring